Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas F Fitz

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Neurobiology of Disease|August 19, 2021
Small nucleolar RNAs in plasma extracellular vesicles and their discriminatory power as diagnostic biomarkers of Alzheimer's diseaseNicholas F Fitz, Jiebiao Wang, M Ilyas Kamboh, et al.
International Journal of Molecular Sciences|August 26, 2023
Extracellular Vesicles in Young Serum Contribute to the Restoration of Age-Related Brain Transcriptomes and Cognition in Old MiceNicholas F Fitz, Amrita Sahu, Yi Lu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersYifan Zhao, Tao Jin, Nicholas F Fitz, et al.
International Journal of Molecular Sciences|December 28, 2018
The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and PerspectivesCody M Wolfe, Nicholas F Fitz, Kyong Nyon Nam, et al.
ASN Neuro|July 3, 2009
Memory deficits in APP23/Abca1+/- mice correlate with the level of Aβ oligomersIliya Lefterov, Nicholas F Fitz, Andrea Cronican, et al.
Neurobiology of Disease|June 15, 2015
RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatmentIliya Lefterov, Jonathan Schug, Anais Mounier, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Brain single-cell transcriptional responses to bexarotene-activated RXR in Alzheimer's disease modelCarolina Saibro-Girardi, Yi Lu, Nicholas F Fitz, et al.
Journal of Alzheimer'S Disease : JAD|March 20, 2014
Improvement of memory deficits and amyloid-β clearance in aged APP23 mice treated with a combination of anti-amyloid-β antibody and LXR agonistNicholas F Fitz, Emilie L Castranio, Alexis Y Carter, et al.
International Journal of Molecular Sciences|March 14, 2026
Brain Single-Cell Transcriptional Responses to Bexarotene-Activated RXR in an Alzheimer's Disease ModelCarolina Saibro-Girardi, Yi Lu, Nicholas F Fitz, et al.
Scientific Reports|April 8, 2016
RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomersKyong Nyon Nam, Anais Mounier, Nicholas F Fitz, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Neurobiology of Disease|August 19, 2021
Small nucleolar RNAs in plasma extracellular vesicles and their discriminatory power as diagnostic biomarkers of Alzheimer's diseaseNicholas F Fitz, Jiebiao Wang, M Ilyas Kamboh, et al.
International Journal of Molecular Sciences|August 26, 2023
Extracellular Vesicles in Young Serum Contribute to the Restoration of Age-Related Brain Transcriptomes and Cognition in Old MiceNicholas F Fitz, Amrita Sahu, Yi Lu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersYifan Zhao, Tao Jin, Nicholas F Fitz, et al.
International Journal of Molecular Sciences|December 28, 2018
The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and PerspectivesCody M Wolfe, Nicholas F Fitz, Kyong Nyon Nam, et al.
ASN Neuro|July 3, 2009
Memory deficits in APP23/Abca1+/- mice correlate with the level of Aβ oligomersIliya Lefterov, Nicholas F Fitz, Andrea Cronican, et al.
Neurobiology of Disease|June 15, 2015
RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatmentIliya Lefterov, Jonathan Schug, Anais Mounier, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Brain single-cell transcriptional responses to bexarotene-activated RXR in Alzheimer's disease modelCarolina Saibro-Girardi, Yi Lu, Nicholas F Fitz, et al.
Journal of Alzheimer'S Disease : JAD|March 20, 2014
Improvement of memory deficits and amyloid-β clearance in aged APP23 mice treated with a combination of anti-amyloid-β antibody and LXR agonistNicholas F Fitz, Emilie L Castranio, Alexis Y Carter, et al.
International Journal of Molecular Sciences|March 14, 2026
Brain Single-Cell Transcriptional Responses to Bexarotene-Activated RXR in an Alzheimer's Disease ModelCarolina Saibro-Girardi, Yi Lu, Nicholas F Fitz, et al.
Scientific Reports|April 8, 2016
RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomersKyong Nyon Nam, Anais Mounier, Nicholas F Fitz, et al.
Pageof 5